arrow
D

David McCall

the university of texas m d anderson cancer center
H指数:24
被引数:2,153

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia

奥佐米星在唐氏综合征和急性淋巴细胞白血病患者中的应用

Leukemia
IF13.4
2026-06-030
PRE
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML

FLAG-IDA联合venetoclax方案用于新诊断AML的儿童、青少年及年轻成年患者

Blood
IF23.1
2025-09-220
PRE
Risk of early death after acute leukemia diagnosis among adolescents and young adults

青少年和年轻成人急性白血病诊断后的早期死亡风险

2025-08-011
PRE
Phase II Study of Pedi-Crib: Mini-Hyper-CVD with Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric Patients with B-Cell Lineage Acute Lymphocytic Leukemia

II期研究:Pedi-Crib方案——浓缩利妥昔单抗、伊诺妥单抗奥佐米星和吉妥单抗奥佐米星(cRIB)用于B细胞系急性淋巴细胞白血病儿科患者复发后的治疗

BLOOD
IF23.1
2024-11-051
PRE
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community

儿童急性白血病中的Menin抑制剂: 全面回顾和建议,以加速与成人白血病和国际社会合作的进展

LEUKEMIA
IF13.4
2024-08-230
OAAI
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
LEUKEMIA
IF13.4
2023-07-1411
OAAI
Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022
2022-11-017
OA
A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy
2022-10-243
OAAI
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
2022-06-0117
OAAI